Hydrogen + Oxygen + Sulfur Compounds (H + O + S)
Found 219,213 compounds containing Hydrogen + Oxygen + Sulfur. Page 13 of 4385.
H
Hydrogen
Lightest element, forms water with oxygen
O
Oxygen
Essential for respiration
S
Sulfur
Yellow nonmetal
| Formula | IUPAC Name | Common Name | Mol. Weight |
|---|---|---|---|
| C25H40O2S | 15-(1-methoxycyclopentoxy)-2,16-dimethyl-5-thiapentacyclo[9.7.0.02,8.04,6.012,16]octadecane | 15-(1-methoxycyclopentoxy)-2,16-dimethyl-5-thiapentacyclo[9.7.0.02,8.04,6.012,16]octadecane | 404.70 |
| C11H9N3O3S | 4,6-dioxo-N-phenyl-2-sulfanyl-1H-pyrimidine-5-carboxamide | 4,6-dioxo-N-phenyl-2-sulfanyl-1H-pyrimidine-5-carboxamide | 263.27 |
| C26H32N3NaO6S2 | sodium 3-[2-[4-(1,3-dibutyl-4,6-dioxo-2-thioxo-hexahydropyrimidin-5-ylidene)but-2-enylidene]-1,3-benzoxazol-3-yl]propane-1-sulfonate | DTXSID8069646 | 569.70 |
| C26H33N3O6S2 | 3-[2-[4-(1,3-dibutyl-4,6-dioxo-2-thioxo-hexahydropyrimidin-5-ylidene)but-2-enylidene]-1,3-benzoxazol-3-yl]propane-1-sulfonic acid | SCHEMBL5586053 | 547.70 |
| C17H27N3O6S | 2-(1-carboxy-2-hydroxy-propyl)-4-[5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-3-methyl-3,4-dihydro-2H-pyrrole-5-carboxylic acid | 2-(1-carboxy-2-hydroxypropyl)-4-{[5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-3-methyl-3,4-dihydro-2h-pyrrole-5-carboxylic acid | 401.50 |
| C2H5O3S2- | 2-sulfanylethanesulfonate | 2-mercaptoethanesulfonate | 141.19 |
| C21H26N2OS2 | 10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylsulfinyl-phenothiazine | mesoridazine | 386.60 |
| C19H27N3O2S | 1-(4,7-dimethyl-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinolin-9-yl)-N,N-dimethyl-methanesulfonamide | [3H]mesulergine | 361.50 |
| C46H83N11O14S2 | 5-[2-[[2-[[6-amino-2-[[6-amino-2-[[2-[[5-amino-2-[(2-amino-4-methylsulfanyl-butanoyl)amino]-5-oxo-pentanoyl]amino]-4-methylsulfanyl-butanoyl]amino]hexanoyl]amino]hexanoyl]amino]-3-methyl-butanoyl]amino]hexanoylamino]-2-(hydroxymethyl)-4-oxo-heptanedioic acid | 5-[2-[[2-[[6-amino-2-[[6-amino-2-[[2-[[5-amino-2-[(2-amino-4-methylsulfanyl-butanoyl)amino]-5-oxo-pentanoyl]amino]-4-methylsulfanyl-butanoyl]amino]hexanoyl]amino]hexanoyl]amino]-3-methyl-butanoyl]amino]hexanoylamino]-2-(hydroxymethyl)-4-oxo-heptanedioic acid | 1078.40 |
| C17H18N3O4S- | 3,3-dimethyl-6-[[2-(methyleneamino)-2-phenyl-acetyl]amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate | NCGC00178294-01 | 360.40 |
| C17H19N3O4S | 3,3-dimethyl-6-[[2-(methyleneamino)-2-phenyl-acetyl]amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | (2S,5R,6R)-3,3-Dimethyl-6-((R)-2-(methyleneamino)-2-phenylacetamido)-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | 361.40 |
| C2H8NO2PS | [amino(methylsulfanyl)phosphoryl]oxymethane | methamidophos | 141.13 |
| C5H8N4O3S2 | N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide | methazolamide | 236.30 |
| C17H19N2O6S- | 6-[(2,6-dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate | 6-[(2,6-dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate | 379.40 |
| C17H20N2O6S | 6-[(2,6-dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | Methcillin | 380.40 |
| C20H31N3O4S | 2-[[2-[(2-amino-4-methylsulfanyl-butanoyl)amino]-4-methyl-pentanoyl]amino]-3-phenyl-propanoic acid | Met-Leu-Phe acetate salt | 409.50 |
| C5H10N2O2S | methyl N-(methylcarbamoyloxy)ethanimidothioate | methomyl | 162.21 |
| C9H11Cl2N3O4S2 | 6-chloro-3-(chloromethyl)-2-methyl-1,1-dioxo-3,4-dihydro-1lambda6,2,4-benzothiadiazine-7-sulfonamide | methyclothiazide | 360.20 |
| C14H11N3O3S | methyl N-[6-(thiophene-2-carbonyl)-1H-benzimidazol-2-yl]carbamate | nocodazole | 301.32 |
| C8H10NO5PS | dimethoxy-(4-nitrophenoxy)-thioxo-lambda5-phosphane | Parathion-methyl | 263.21 |
| C15H15NO2S | 4-(2-phenylsulfanylethyl)benzenecarbohydroxamic acid | HDInhib_000021 | 273.40 |
| C18H16N2O4S | 2-[4-(2-naphthylsulfonylamino)phenyl]ethanehydroxamic acid | HDInhib_000022 | 356.40 |
| C15H16N2O4S | 3-[4-(benzenesulfonamido)phenyl]propanehydroxamic acid | CHEMBL98346 | 320.40 |
| C21H18N2O4S | 3-[4-[(4-phenylphenyl)sulfonylamino]phenyl]prop-2-enehydroxamic acid | SCHEMBL1403505 | 394.40 |
| C21H16N2O4S | 3-[4-[(4-phenylphenyl)sulfonylamino]phenyl]prop-2-ynehydroxamic acid | HDInhib_000025 | 392.40 |
| C19H21NO3S | 5-[2-oxo-2-(4-phenylphenyl)ethyl]sulfanylpentanehydroxamic acid | HDInhib_000029 | 343.40 |
| C15H14N2O4S | 3-[4-(benzenesulfonamido)phenyl]prop-2-enehydroxamic acid | 3-(4-Benzenesulfonylaminophenyl)-N-hydroxyacrylamide | 318.30 |
| C16H16N2O4S | 3-[4-(benzenesulfonamido)phenyl]-2-methyl-prop-2-enehydroxamic acid | 3-[4-(benzenesulfonamido)phenyl]-2-methyl-prop-2-enehydroxamic acid | 332.40 |
| C16H16N2O4S | 3-[4-[benzenesulfonyl(methyl)amino]phenyl]prop-2-enehydroxamic acid | 3-[4-[benzenesulfonyl(methyl)amino]phenyl]prop-2-enehydroxamic acid | 332.40 |
| C17H18N2O6S | 3-[4-[(3,4-dimethoxyphenyl)sulfonylamino]phenyl]prop-2-enehydroxamic acid | SCHEMBL1403549 | 378.40 |
| C2H6O3S | methyl methanesulfonate | METHYL METHANESULFONATE | 110.13 |
| C5H6N2OS | 6-methyl-2-sulfanyl-1H-pyrimidin-4-one | 6-methyl-2-sulfanyl-1H-pyrimidin-4-one | 142.18 |
| C15H13NO2S | 2-(10-methylphenothiazin-2-yl)acetic acid | metiazinic acid | 271.30 |
| C10H13NO4S2 | 6-methyl-1,1-dioxo-3,4-dihydro-2H-thiochromene-7-sulfonamide | meticrane | 275.30 |
| C16H16ClN3O3S | 7-chloro-2-methyl-3-(o-tolyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide | metolazone | 365.80 |
| C8H16NNaO5S2 | sodium N-methyl-N-(2,3,4,5,6-pentahydroxyhexyl)carbamodithioate | sodium N-methyl-N-(2,3,4,5,6-pentahydroxyhexyl)carbamodithioate | 293.30 |
| C8H17NO5S2 | methyl(2,3,4,5,6-pentahydroxyhexyl)carbamodithioic acid | MDCG | 271.40 |
| C9H11O7S- | [4-(1,2-dihydroxyethyl)-2-methoxy-phenyl] sulfate | 1,2-Ethanediol,1-[3-methoxy-4-(sulfooxy)phenyl]-, potassium salt (1:1) | 263.25 |
| C9H12O7S | [4-(1,2-dihydroxyethyl)-2-methoxy-phenyl] hydrogen sulfate | MOPEG sulfate | 264.25 |
| C48H49N13O9S6 | 2-[2-[12,26-di(ethylidene)-29-(1-hydroxyethyl)-19-isopropyl-14,21,28,31-tetraoxo-10,17,24,34-tetrathia-6,13,20,27,30,35,36,37,38-nonazahexacyclo[30.2.1.18,11.115,18.122,25.02,7]octatriaconta-1(35),2(7),3,5,8,11(38),15,18(37),22,25(36),32-undecaen-5-yl]thiazol-4-yl]-N-[2-hydroxy-1-(2-hydroxypropylcarbamoyl)propyl]thiazole-4-carboxamide | 2-[2-[12,26-di(ethylidene)-29-(1-hydroxyethyl)-19-isopropyl-14,21,28,31-tetraoxo-10,17,24,34-tetrathia-6,13,20,27,30,35,36,37,38-nonazahexacyclo[30.2.1.18,11.115,18.122,25.02,7]octatriaconta-1(35),2(7),3,5,8,11(38),15,18(37),22,25(36),32-undecaen-5-yl]thiazol-4-yl]-N-[2-hydroxy-1-(2-hydroxypropylcarbamoyl)propyl]thiazole-4-carboxamide | 1144.40 |
| C9H15N5O4S | [2,6-diamino-4-(1-piperidyl)pyrimidin-1-ium-1-yl] sulfate | Minoxidil sulfate salt | 289.31 |
| C9H16N5O4S+ | [2,6-diamino-4-(1-piperidyl)pyrimidin-1-ium-1-yl] hydrogen sulfate | (2,6-diamino-4-piperidin-1-ylpyrimidin-1-ium-1-yl) hydrogen sulfate | 290.32 |
| C15H17IN2O2S | 1-[(5-iodo-1-naphthyl)sulfonyl]-1,4-diazepane | RefChem:913479 | 416.30 |
| C15H17ClN2O2S | 1-[(5-chloro-1-naphthyl)sulfonyl]-1,4-diazepane | ML-9 free base | 324.80 |
| C21H27N3O8S2 | 1,3-bis[(4-methoxyphenyl)sulfonyl]-5,5-dimethyl-hexahydropyrimidine-2-carbohydroxamic acid | mmp inhibitor ii | 513.60 |
| C21H23N7O2S2 | 1-[1-benzyl-2-oxo-2-[4-(2-pyridyl)piperazin-1-yl]ethyl]-3-(5-sulfanyl-1,3,4-thiadiazol-2-yl)urea | 1-[1-benzyl-2-oxo-2-[4-(2-pyridyl)piperazin-1-yl]ethyl]-3-(5-sulfanyl-1,3,4-thiadiazol-2-yl)urea | 469.60 |
| C21H19NO4S | 3-phenyl-2-[(4-phenylphenyl)sulfonylamino]propanoic acid | gelatinase A | 381.40 |
| C21H20N2O4S | 3-phenyl-2-[(4-phenylphenyl)sulfonylamino]propanehydroxamic acid | 3-phenyl-2-[(4-phenylphenyl)sulfonylamino]propanehydroxamic acid | 396.50 |
| C14H22N2O5S | 2-[(4-methoxyphenyl)sulfonyl-(1-methylbutyl)amino]ethanehydroxamic acid | 2-[(4-methoxyphenyl)sulfonyl-(1-methylbutyl)amino]ethanehydroxamic acid | 330.40 |
| C19H25N5O2S2 | N-(cyclohexylmethyl)-3-phenyl-2-[(5-sulfanyl-1,3,4-thiadiazol-2-yl)carbamoylamino]propanamide | N-(cyclohexylmethyl)-3-phenyl-2-[(5-sulfanyl-1,3,4-thiadiazol-2-yl)carbamoylamino]propanamide | 419.60 |